PNC FINANCIAL SERVICES GROUP, INC. - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 62 filers reported holding SPERO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$0
-100.0%
14
-100.0%
0.00%
Q4 2019$308,000
-9.4%
32,0000.0%0.00%
Q3 2019$340,000
-7.6%
32,0000.0%0.00%
Q2 2019$368,000
-10.2%
32,0000.0%0.00%
Q1 2019$410,000
+318.4%
32,000
+102.5%
0.00%
Q4 2018$98,000
-7.5%
15,800
+58.0%
0.00%
Q3 2018$106,000
-27.4%
10,0000.0%0.00%
Q2 2018$146,00010,0000.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders